Real-world care for blood cancer patients receiving CAR-T therapy
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how patients with blood cancers are managed in real life when they receive CAR-T cell therapy. It helps doctors learn more about how well these treatments work outside of clinical trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer that your doctor thinks can be treated with CAR-T cells.
- You are being treated at Toulouse University Hospital in France.
- Your CAR-T treatment is given between January 2019 and December 2028.
- You understand the study and are okay with your data being used.
- You are not under a legal guardianship or court protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and stores biological samples from people who have been treated with CAR-T cells at the University Hospital of Montpellier. Your samples can help researchers learn more about treatment effects and safety.
This study is for people with blood cancers who are treated with CAR-T cell therapy. Researchers will follow participants over time to learn more about how this therapy works in the real world.
This study collects health data from people in France who received CAR-T treatment or are eligible to receive it. It helps doctors and researchers understand who can get CAR-T and how treatment is used in real life.
This study looks at immune system “fingerprints” in people who are planning to receive CAR-T cells. It may help doctors understand how the immune system responds to CAR-T and improve future care.
This study looks at tissue samples from adults who are receiving CAR-T cell therapy for blood-related conditions. It aims to learn more about how CAR-T works and what changes happen in the body, which may help improve future care.
This Phase 1 study looks at whether it is safe and practical to collect your own stem cells and use them to support CAR T-cell therapy for certain blood cancers that have come back or did not respond. It aims to find the best way to combine these steps, which may help some people receive CAR T treatment.
Hear when a new Hemopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.